Insider Trading activities of Biogen Inc. insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biogen Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biogen Inc. since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Biogen Inc. since 2005. The reporting company's ticker symbol is BIIB. The reporting company's CIK number is 875045.
The total value of stock buying since 2005 is $119,996,839.
The total value of stock sales since 2005 is $580,098,411.
The total value of stock option exercises since 2005 is $243,892,560.



Table 2. Detailed insider stock purchases, sales, and option exercises of Biogen Inc. insiders (BIIB) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-03-04 Sandrock Alfred (Grp SVP, Chief Medical Officer) Sale 3,171 342.58 1,086,321
2014-03-03 Scangos George A (Chief Executive Officer) Sale 2,942 335.79 987,894
2014-02-26 Sandrock Alfred (Grp SVP, Chief Medical Officer) Sale 1,048 342.17 358,594
2014-02-23 Sandrock Alfred (Grp SVP, Chief Medical Officer) Option Ex 1,988 .00 0
2014-02-23 Cox John (EVP Pharmaceutical Oper & Tech) Option Ex 2,598 .00 0
2014-02-23 Clancy Paul J (Executive VP and CFO) Option Ex 4,280 .00 0
2014-02-23 Alexander Susan H (EVP, Chief Legal Officer) Option Ex 3,821 .00 0
2014-02-18 Holtzman Steven H (EVP Corporate Development) Sale 1,222 327.90 400,693
2014-02-13 Dipietro Kenneth (EVP Human Resources) Sale 1,290 316.81 408,684
2014-02-13 Scangos George A (Chief Executive Officer) Sale 486 316.81 153,969
2014-02-12 Artavanis-tsakonas Spyridon (SVP, Chief Scientific Officer) Option Ex 714 .00 0
2014-02-12 Dipietro Kenneth (EVP Human Resources) Option Ex 2,246 .00 0
2014-02-12 Cox John (EVP Pharmaceutical Oper & Tech) Option Ex 2,246 .00 0
2014-02-12 Clancy Paul J (Executive VP and CFO) Option Ex 2,807 .00 0
2014-02-12 Kingsley Stuart A (EVP, Global Comm. Operations) Option Ex 2,246 .00 0
2014-02-12 Holtzman Steven H (EVP Corporate Development) Option Ex 2,142 .00 0
2014-02-12 Alexander Susan H (EVP, Chief Legal Officer) Option Ex 2,142 .00 0
2014-02-12 Covino Gregory F (VP, Chief Accounting Officer) Option Ex 315 .00 0
2014-02-12 Scangos George A (Chief Executive Officer) Option Ex 9,189 .00 0
2014-02-12 Williams Douglas E (EVP Research & Development) Option Ex 3,573 .00 0
2014-02-11 Sandrock Alfred (Grp SVP, Chief Medical Officer) Sale 2,085 314.31 655,336
2014-02-11 Scangos George A (Chief Executive Officer) Sale 2,456 314.31 771,945
2014-02-10 Scangos George A (Chief Executive Officer) Option Ex 18,833 .00 0
2014-02-09 Sandrock Alfred (Grp SVP, Chief Medical Officer) Option Ex 1,824 .00 0
2014-02-09 Cox John (EVP Pharmaceutical Oper & Tech) Option Ex 4,691 .00 0
2014-02-09 Clancy Paul J (Executive VP and CFO) Option Ex 4,691 .00 0
2014-02-09 Kingsley Stuart A (EVP, Global Comm. Operations) Option Ex 1,824 .00 0
2014-02-09 Alexander Susan H (EVP, Chief Legal Officer) Option Ex 3,909 .00 0
2014-02-09 Scangos George A (Chief Executive Officer) Option Ex 11,270 .00 0
2014-02-08 Sandrock Alfred (Grp SVP, Chief Medical Officer) Option Ex 1,277 .00 0
2014-02-08 Cox John (EVP Pharmaceutical Oper & Tech) Option Ex 4,023 .00 0
2014-02-08 Clancy Paul J (Executive VP and CFO) Option Ex 3,191 .00 0
2014-02-08 Kingsley Stuart A (EVP, Global Comm. Operations) Option Ex 2,636 .00 0
2014-02-08 Holtzman Steven H (EVP Corporate Development) Option Ex 2,705 .00 0
2014-02-08 Alexander Susan H (EVP, Chief Legal Officer) Option Ex 2,498 .00 0
2014-02-08 Williams Douglas E (EVP Research & Development) Option Ex 3,468 .00 0
2014-02-04 Dipietro Kenneth (EVP Human Resources) Sale 1,655 299.01 494,861
2014-02-01 Dipietro Kenneth (EVP Human Resources) Option Ex 2,463 .00 0
2014-02-01 Kingsley Stuart A (EVP, Global Comm. Operations) Option Ex 4,586 .00 0
2014-02-01 Holtzman Steven H (EVP Corporate Development) Option Ex 5,159 .00 0
2014-02-01 Williams Douglas E (EVP Research & Development) Option Ex 5,159 .00 0
2014-01-21 Rowinsky Eric K (Director) Sale 2,020 310.09 626,381
2014-01-15 Schenk Lynn (Director) Sale 1,000 297.48 297,480
2014-01-08 Young William (Director) Sale 15,000 285.11 4,276,590
2014-01-06 Pangia Robert W (Director) Sale 6,250 278.03 1,737,687
2014-01-06 Pangia Robert W (Director) Option Ex 6,250 47.55 297,187
2014-01-02 Sherwin Stephen A (Director) Sale 5,500 279.17 1,535,429
2014-01-02 Sherwin Stephen A (Director) Option Ex 5,500 59.82 329,010
2013-12-04 Sandrock Alfred (Grp SVP, Chief Medical Officer) Sale 439 285.90 125,510
2013-12-02 Schenk Lynn (Director) Sale 1,000 291.71 291,710
2013-11-22 Pawlicki Raymond (SVP, Chief Information Officer) Sale 4,000 288.00 1,152,000
2013-11-22 Pawlicki Raymond (SVP, Chief Information Officer) Option Ex 4,000 49.95 199,800
2013-11-01 Schenk Lynn (Director) Sale 1,000 245.00 245,000
2013-11-01 Scangos George A (Chief Executive Officer) Sale 2,239 245.57 549,831
2013-10-22 Sandrock Alfred (Grp SVP, Chief Medical Officer) Sale 15,030 250.11 3,759,123
2013-10-22 Sandrock Alfred (Grp SVP, Chief Medical Officer) Option Ex 15,030 60.56 910,216
2013-10-01 Schenk Lynn (Director) Sale 1,000 242.85 242,850
2013-10-01 Scangos George A (Chief Executive Officer) Sale 2,239 242.85 543,741
2013-09-30 Dipietro Kenneth (EVP Human Resources) Sale 1,440 242.00 348,480
2013-09-18 Clancy Paul J (Executive VP and CFO) Sale 26,785 245.00 6,562,325
2013-09-18 Clancy Paul J (Executive VP and CFO) Option Ex 26,785 49.65 1,329,875
2013-09-17 Holtzman Steven H (EVP Corporate Development) Sale 3,501 238.98 836,668
2013-09-16 Sandrock Alfred (Grp SVP, Chief Medical Officer) Sale 9,820 240.10 2,357,821
2013-09-16 Sandrock Alfred (Grp SVP, Chief Medical Officer) Option Ex 9,820 49.65 487,563
2013-09-16 Pawlicki Raymond (SVP, Chief Information Officer) Sale 4,000 238.03 952,120
2013-09-16 Pawlicki Raymond (SVP, Chief Information Officer) Option Ex 4,000 49.59 198,360
2013-09-16 Clancy Paul J (Executive VP and CFO) Sale 99,030 238.47 23,615,882
2013-09-16 Clancy Paul J (Executive VP and CFO) Option Ex 99,030 51.74 5,123,614
2013-09-11 Schenk Lynn (Director) Sale 900 235.25 211,725
2013-09-03 Scangos George A (Chief Executive Officer) Sale 2,239 214.88 481,116
2013-08-26 Williams Douglas E (EVP Research & Development) Sale 4,368 211.35 923,168
2013-08-01 Scangos George A (Chief Executive Officer) Sale 2,239 218.82 489,937
2013-07-16 Scangos George A (Chief Executive Officer) Sale 2,239 223.94 501,401
2013-07-15 Scangos George A (Chief Executive Officer) Option Ex 21,339 .00 0
2013-06-14 Denner Alexander J (Director) Sale 2,900 212.00 614,800
2013-06-11 Posner Brian S (Director) Sale 2,020 219.62 443,632
2013-06-11 Papadopoulos Stelios (Director) Sale 2,020 219.62 443,632
2013-06-10 Schenk Lynn (Director) Sale 2,000 225.82 451,634
2013-06-03 Scangos George A (Chief Executive Officer) Sale 1,598 234.16 374,187
2013-06-03 Sherwin Stephen A (Director) Sale 12,825 233.02 2,988,532
2013-06-03 Sherwin Stephen A (Director) Option Ex 12,825 59.82 767,191
2013-05-29 Mulligan Richard (Director) Option Ex 3,000 53.43 160,290
2013-05-29 Denner Alexander J (Director) Option Ex 3,000 53.43 160,290
2013-05-28 Mulligan Richard (Director) Sale 37,975 239.85 9,108,265
2013-05-28 Mulligan Richard (Director) Option Ex 37,975 53.43 2,029,004
2013-05-28 Denner Alexander J (Director) Sale 37,975 239.77 9,105,113
2013-05-28 Denner Alexander J (Director) Option Ex 37,975 53.43 2,029,004
2013-05-28 Pangia Robert W (Director) Sale 5,900 237.23 1,399,657
2013-05-01 Covino Gregory F (VP, Chief Accounting Officer) Option Ex 347 .00 0
2013-05-01 Scangos George A (Chief Executive Officer) Sale 1,598 215.39 344,193
2013-04-30 Clancy Paul J (Executive VP and CFO) Sale 14,489 224.58 3,253,925
2013-04-29 Clancy Paul J (Executive VP and CFO) Sale 9,123 219.71 2,004,414
2013-04-01 Scangos George A (Chief Executive Officer) Sale 1,598 193.66 309,468
2013-03-22 Mulligan Richard (Director) Sale 2,900 176.88 512,952
2013-03-22 Sherwin Stephen A (Director) Sale 1,500 176.88 265,320
2013-03-18 Posner Brian S (Director) Sale 4,500 174.81 786,645
2013-03-13 Mulligan Richard (Director) Sale 7,980 175.25 1,398,510
2013-03-11 Papadopoulos Stelios (Director) Sale 46,675 172.48 8,050,457
2013-03-11 Papadopoulos Stelios (Director) Option Ex 46,675 57.26 2,672,470
2013-03-01 Scangos George A (Chief Executive Officer) Sale 1,598 165.30 264,149
2013-02-23 Pawlicki Raymond (SVP, Chief Information Officer) Option Ex 1,529 .00 0
2013-02-23 Cox John (EVP Pharmaceutical Oper & Tech) Option Ex 2,598 .00 0
2013-02-23 Clancy Paul J (Executive VP and CFO) Option Ex 4,281 .00 0
2013-02-23 Alexander Susan H (EVP, Chief Legal Officer) Option Ex 3,821 .00 0
2013-02-13 Scangos George A (Chief Executive Officer) Sale 1,598 163.39 261,097
2013-02-10 Scangos George A (Chief Executive Officer) Option Ex 18,833 .00 0
2013-02-09 Pawlicki Raymond (SVP, Chief Information Officer) Option Ex 1,890 .00 0
2013-02-09 Cox John (EVP Pharmaceutical Oper & Tech) Option Ex 4,692 .00 0
2013-02-09 Clancy Paul J (Executive VP and CFO) Option Ex 4,692 .00 0
2013-02-09 Kingsley Stuart A (EVP, Global Comm. Operations) Option Ex 1,824 .00 0
2013-02-09 Alexander Susan H (EVP, General Counsel) Option Ex 3,909 .00 0
2013-02-09 Scangos George A (Chief Executive Officer) Option Ex 9,767 .00 0
2013-02-08 Pawlicki Raymond (SVP, Chief Information Officer) Option Ex 1,106 .00 0
2013-02-08 Cox John (EVP Pharmaceutical Oper & Tech) Option Ex 3,487 .00 0
2013-02-08 Clancy Paul J (Executive VP and CFO) Option Ex 2,765 .00 0
2013-02-08 Kingsley Stuart A (EVP, Global Comm. Operations) Option Ex 2,284 .00 0
2013-02-08 Holtzman Steven H (EVP Corporate Development) Option Ex 2,344 .00 0
2013-02-08 Alexander Susan H (EVP, General Counsel) Option Ex 2,165 .00 0
2013-02-08 Williams Douglas E (EVP Research & Development) Option Ex 3,006 .00 0
2013-02-06 Pawlicki Raymond (SVP, Chief Information Officer) Sale 10,000 165.55 1,655,500
2013-02-06 Pawlicki Raymond (SVP, Chief Information Officer) Option Ex 10,000 49.65 496,500
2013-02-06 Pangia Robert W (Director) Sale 2,500 165.55 413,875
2013-02-06 Pangia Robert W (Director) Option Ex 2,500 66.29 165,725
2013-02-01 Kingsley Stuart A (EVP, Global Comm. Operations) Option Ex 4,586 .00 0
2013-02-01 Williams Douglas E (EVP Research & Development) Option Ex 5,159 .00 0
2012-12-27 Denner Alexander J (Director) Sale 3,991 148.53 592,799
2012-12-26 Denner Alexander J (Director) Sale 3,989 148.89 593,914
2012-11-01 Scangos George A (Chief Executive Officer) Sale 2,472 139.28 344,292
2012-10-01 Scangos George A (Chief Executive Officer) Sale 3,654 149.16 545,030
2012-09-17 Pangia Robert W (Director) Sale 5,000 155.00 775,000
2012-09-17 Pangia Robert W (Director) Option Ex 5,000 66.29 331,450
2012-09-06 Pangia Robert W (Director) Sale 5,000 150.00 750,000
2012-09-06 Pangia Robert W (Director) Option Ex 5,000 66.29 331,450
2012-09-04 Scangos George A (Chief Executive Officer) Sale 3,654 145.90 533,118
2012-09-04 Sherwin Stephen A (Director) Sale 2,000 145.90 291,800
2012-08-02 Alexander Susan H (EVP, General Counsel) Sale 1,165 142.99 166,583
2012-08-01 Scangos George A (Chief Executive Officer) Sale 3,655 146.30 534,726
2012-07-27 Alexander Susan H (EVP, General Counsel) Sale 58,070 150.00 8,710,500
2012-07-27 Alexander Susan H (EVP, General Counsel) Option Ex 58,070 55.10 3,199,947
2012-07-17 Scangos George A (Chief Executive Officer) Sale 2,472 146.04 361,010
2012-07-16 Scangos George A (Chief Executive Officer) Option Ex 21,339 .00 0
2012-07-02 Scangos George A (Chief Executive Officer) Sale 1,183 143.50 169,760
2012-06-19 Pawlicki Raymond (SVP, Chief Information Officer) Sale 10,000 143.00 1,430,000
2012-06-19 Pawlicki Raymond (SVP, Chief Information Officer) Option Ex 10,000 49.59 495,900
2012-06-15 Alexander Susan H (EVP, General Counsel) Sale 49,800 140.00 6,972,000
2012-06-15 Alexander Susan H (EVP, General Counsel) Option Ex 49,800 47.52 2,366,247
2012-06-15 Pangia Robert W (Director) Sale 5,000 140.00 700,000
2012-06-15 Pangia Robert W (Director) Option Ex 5,000 36.94 184,700
2012-06-07 Posner Brian S (Director) Sale 2,500 135.00 337,500
2012-06-07 Posner Brian S (Director) Option Ex 2,500 71.38 178,450

Insider trading activities including stock purchases, stock sales, and option exercises of BIIB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biogen Inc. (symbol BIIB, CIK number 875045) see the Securities and Exchange Commission (SEC) website.